8 Results for "

OTC

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "OTC" in MCE Product Catalog:

Cat. No.: HY-125947
CAS No.: 14206-58-7
Purity:  99.16%
Target:  

Drug Metabolite

Research Areas:  

Others

4-Epioxytetracycline, the degradation product of Oxytetracycline (OTC), can be found in swine manure compost and wastewater .
loading...
    loading...
Cat. No.: HY-125947R
CAS No.: 14206-58-7
Research Areas:  

Others

4-Epioxytetracycline (Standard) is the analytical standard of 4-Epioxytetracycline. This product is intended for research and analytical applications. 4-Epioxytetracycline, the degradation product of Oxytetracycline (OTC), can be found in swine manure compost and wastewater .
loading...
    loading...
Cat. No.: HY-RS09859
Research Areas:  

Others

OTC Human Pre-designed siRNA Set A contains three designed siRNAs for OTC gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS17937
Research Areas:  

Others

Otc Mouse Pre-designed siRNA Set A contains three designed siRNAs for Otc gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS24408
Research Areas:  

Others

Otc Rat Pre-designed siRNA Set A contains three designed siRNAs for Otc gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-P81485
Synonyms: OTCase; Ornithine carbamoyltransferase; mitochondrial; OCTD

Host:  

Rabbit

Application:  

IHC-P

Reactivity:  

Human

loading...
    loading...
Cat. No.: HY-P81485A
Synonyms: OTCase; Ornithine carbamoyltransferase; mitochondrial; OCTD

Host:  

Rabbit

Application:  

IHC-P

Reactivity:  

Human

loading...
    loading...
Cat. No.: HY-L076
641 compounds

Drug-induced liver injury (DILI; also known as drug-induced hepatotoxicity) is caused by medications (prescription or OTC), herbal and dietary supplements (HDS), or other xenobiotics that result in abnormalities in liver tests or in hepatic dysfunction that cannot be explained by other causes. Drugs are an important cause of liver injury. Drug-induced hepatic injury is the most common reason cited for withdrawal of an approved drug.

DILI is thought to occur via several different mechanisms. Among these are direct impairment of the structural (e.g., mitochondrial dysfunction) and functional integrity of the liver; production of a metabolite that alters hepatocellular structure and function; production of a reactive drug metabolite that binds to hepatic proteins to produce new antigenic drug-protein adducts, which are targeted by hosts’ defenses (the hapten hypothesis); and initiation of a systemic hypersensitivity response (i.e., drug allergy) that damages the liver.

MCE Drug-induced Liver Injury (DILI) Compound Library contains a unique collection of 641 hepatotoxicity causing compounds and is a powerful tool to research DILI and other drug toxicities. This library can be used to understand the mechanisms of DILI, identify biomarkers for early DILI prediction, and allow timely recognition during drug development, thus finally achieving successful DILI prevention and assessment in the pre-marketing phase.